A citation-based method for searching scientific literature

Veronika Navrkalova, Karla Plevova, Jakub Hynst, Karol Pal, Andrea Mareckova, Tomas Reigl, Hana Jelinkova, Zuzana Vrzalova, Kamila Stranska, Sarka Pavlova, Anna Panovska, Andrea Janikova, Michael Doubek, Jana Kotaskova, Sarka Pospisilova. J Mol Diagn 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.
S K Tasian, C Hurtz, G B Wertheim, N G Bailey, M S Lim, R C Harvey, I-M Chen, C L Willman, R Astles, A Zebrowski,[...]. Leukemia 2017
39
100

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
Claire Schwab, Sarra L Ryan, Lucy Chilton, Alannah Elliott, James Murray, Stacey Richardson, Christopher Wragg, John Moppett, Michelle Cummins, Oliver Tunstall,[...]. Blood 2016
67
100

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
Jinghui Zhang, Kelly McCastlain, Hiroki Yoshihara, Beisi Xu, Yunchao Chang, Michelle L Churchman, Gang Wu, Yongjin Li, Lei Wei, Ilaria Iacobucci,[...]. Nat Genet 2016
112
100

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.
Ching-Hon Pui, Jun J Yang, Stephen P Hunger, Rob Pieters, Martin Schrappe, Andrea Biondi, Ajay Vora, André Baruchel, Lewis B Silverman, Kjeld Schmiegelow,[...]. J Clin Oncol 2015
399
100

Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
Hagop Kantarjian, Farhad Ravandi, Nicholas J Short, Xuelin Huang, Nitin Jain, Koji Sasaki, Naval Daver, Naveen Pemmaraju, Joseph D Khoury, Jeffrey Jorgensen,[...]. Lancet Oncol 2018
91
100

Why and how to treat Ph-like ALL?
Kathryn G Roberts. Best Pract Res Clin Haematol 2018
17
100

Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review.
Vineeta Yadav, Prasanth Ganesan, Raveendranath Veeramani, Dinesh Kumar V. Clin Lymphoma Myeloma Leuk 2021
1
100

Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.
Brent W Weston, Melissa A Hayden, Kathryn G Roberts, Susan Bowyer, Johann Hsu, George Fedoriw, Kathleen W Rao, Charles G Mullighan. J Clin Oncol 2013
148
100

Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.
Yang Y Ding, Julie W Stern, Tracey F Jubelirer, Gerald B Wertheim, Fumin Lin, Fengqi Chang, Zhaohui Gu, Charles G Mullighan, Yong Li, Richard C Harvey,[...]. Haematologica 2018
24
100

CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
Lauren K Meyer, Cristina Delgado-Martin, Shannon L Maude, Kevin M Shannon, David T Teachey, Michelle L Hermiston. PLoS One 2019
4
100

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Zhaohui Gu, Michelle Churchman, Kathryn Roberts, Yongjin Li, Yu Liu, Richard C Harvey, Kelly McCastlain, Shalini C Reshmi, Debbie Payne-Turner, Ilaria Iacobucci,[...]. Nat Commun 2016
98
100

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Charles G Mullighan, Xiaoping Su, Jinghui Zhang, Ina Radtke, Letha A A Phillips, Christopher B Miller, Jing Ma, Wei Liu, Cheng Cheng, Brenda A Schulman,[...]. N Engl J Med 2009
853
100

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Marketa Zaliova, Jan Stuchly, Lucie Winkowska, Alena Musilova, Karel Fiser, Martina Slamova, Julia Starkova, Martina Vaskova, Ondrej Hrusak, Lucie Sramkova,[...]. Haematologica 2019
32
100


Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.
Donald A Berry, Shouhao Zhou, Howard Higley, Lata Mukundan, Shuangshuang Fu, Gregory H Reaman, Brent L Wood, Gary J Kelloff, J Milburn Jessup, Jerald P Radich. JAMA Oncol 2017
177
100

Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
Lisa J Russell, Lisa Jones, Amir Enshaei, Stefano Tonin, Sarra L Ryan, Jeyanthy Eswaran, Sirintra Nakjang, Elli Papaemmanuil, Jose M C Tubio, Adele K Fielding,[...]. Genes Chromosomes Cancer 2017
24
100

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.
Sarah K Tasian, David T Teachey, Yong Li, Feng Shen, Richard C Harvey, I-Ming Chen, Theresa Ryan, Tiffaney L Vincent, Cheryl L Willman, Alexander E Perl,[...]. Blood 2017
77
100

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
Jie He, Omar Abdel-Wahab, Michelle K Nahas, Kai Wang, Raajit K Rampal, Andrew M Intlekofer, Jay Patel, Andrei Krivstov, Garrett M Frampton, Lauren E Young,[...]. Blood 2016
157
100

Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.
S Köhrer, O Havranek, F Seyfried, C Hurtz, G P Coffey, E Kim, E Ten Hacken, U Jäger, K Vanura, S O'Brien,[...]. Leukemia 2016
41
100

Acute Lymphoblastic Leukemia in Children.
Stephen P Hunger, Charles G Mullighan. N Engl J Med 2015
685
100

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
Kathryn G Roberts, Ryan D Morin, Jinghui Zhang, Martin Hirst, Yongjun Zhao, Xiaoping Su, Shann-Ching Chen, Debbie Payne-Turner, Michelle L Churchman, Richard C Harvey,[...]. Cancer Cell 2012
432
100

ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition.
Kathryn G Roberts, Laura J Janke, Yaqi Zhao, Aman Seth, Jing Ma, David Finkelstein, Steve Smith, Kevin Ebata, Brian B Tuch, Stephen P Hunger,[...]. Blood 2018
19
100

IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
Martin Stanulla, Elif Dagdan, Marketa Zaliova, Anja Möricke, Chiara Palmi, Giovanni Cazzaniga, Cornelia Eckert, Geertruy Te Kronnie, Jean-Pierre Bourquin, Beat Bornhauser,[...]. J Clin Oncol 2018
77
100

Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia.
Santi Suryani, Lauryn S Bracken, Richard C Harvey, Keith C S Sia, Hernan Carol, I-Ming Chen, Kathryn Evans, Philipp A Dietrich, Kathryn G Roberts, Raushan T Kurmasheva,[...]. Mol Cancer Ther 2015
35
100

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Charles G Mullighan, Christopher B Miller, Ina Radtke, Letha A Phillips, James Dalton, Jing Ma, Deborah White, Timothy P Hughes, Michelle M Le Beau, Ching-Hon Pui,[...]. Nature 2008
701
100

Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.
Judith M Boer, Jasper E Koenders, Bronno van der Holt, Carla Exalto, Mathijs A Sanders, Jan J Cornelissen, Peter J M Valk, Monique L den Boer, Anita W Rijneveld. Haematologica 2015
51
100

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.
Kathryn G Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Richard C Harvey, I-Ming Chen, Deqing Pei, Ilaria Iacobucci, Marcus Valentine, Stanley B Pounds,[...]. J Clin Oncol 2017
174
100

TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation.
Kenichiro Kobayashi, Naoyuki Miyagawa, Kazumasa Mitsui, Masaki Matsuoka, Yasuko Kojima, Hiroyuki Takahashi, Kaori Ootsubo, Junichi Nagai, Hitomi Ueno, Takeshi Ishibashi,[...]. Pediatr Blood Cancer 2015
41
100


Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.
Shuo-Chieh Wu, Loretta S Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom,[...]. Cancer Cell 2015
60
100

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
Kathryn G Roberts, Yongjin Li, Debbie Payne-Turner, Richard C Harvey, Yung-Li Yang, Deqing Pei, Kelly McCastlain, Li Ding, Charles Lu, Guangchun Song,[...]. N Engl J Med 2014
712
100

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
Henrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius-Wittsten, Linda Olsson, Christina Orsmark-Pietras, Sofia von Palffy, Maria Askmyr, Marianne Rissler, Martin Schrappe, Gunnar Cario,[...]. Nat Commun 2016
116
100

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.
Parveen Shiraz, Kimberly J Payne, Lori Muffly. Int J Mol Sci 2020
6
100

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
520
100

Acute lymphoblastic leukemia: a comprehensive review and 2017 update.
T Terwilliger, M Abdul-Hay. Blood Cancer J 2017
304
100

Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.
Jodi R Mayfield, David R Czuchlewski, James M Gale, Ksenia Matlawska-Wasowska, Mohammad A Vasef, Christian Nickl, Gavin Pickett, Scott A Ness, Stuart S Winter. Pediatr Blood Cancer 2017
18
100

Clinical utility of targeted NGS panel with comprehensive bioinformatics analysis for patients with acute lymphoblastic leukemia.
Borahm Kim, Hyeonah Lee, Esl Kim, Saeam Shin, Seung-Tae Lee, Jong Rak Choi. Leuk Lymphoma 2019
4
100

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.
Monique L Den Boer, Marjon van Slegtenhorst, Renée X De Menezes, Meyling H Cheok, Jessica G C A M Buijs-Gladdines, Susan T C J M Peters, Laura J C M Van Zutven, H Berna Beverloo, Peter J Van der Spek, Gaby Escherich,[...]. Lancet Oncol 2009
546
100

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Shinsuke Hirabayashi, Kentaro Ohki, Kazuhiko Nakabayashi, Hitoshi Ichikawa, Yukihide Momozawa, Kohji Okamura, Akinori Yaguchi, Kazuki Terada, Yuya Saito, Ai Yoshimi,[...]. Haematologica 2017
72
100

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Yuan-Fang Liu, Bai-Yan Wang, Wei-Na Zhang, Jin-Yan Huang, Ben-Shang Li, Ming Zhang, Lu Jiang, Jian-Feng Li, Ming-Jie Wang, Yu-Jun Dai,[...]. EBioMedicine 2016
123
100

Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population.
Francesca Carobolante, Sabina Chiaretti, Cristina Skert, Renato Bassan. Ther Adv Hematol 2020
11
100

Acute lymphoblastic leukaemia.
Ching-Hon Pui, Leslie L Robison, A Thomas Look. Lancet 2008
929
100

Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion.
Etienne Lengline, Kheïra Beldjord, Hervé Dombret, Jean Soulier, Nicolas Boissel, Emmanuelle Clappier. Haematologica 2013
118
100

Biology, risk stratification, and therapy of pediatric acute leukemias: an update.
Ching-Hon Pui, William L Carroll, Soheil Meshinchi, Robert J Arceci. J Clin Oncol 2011
531
100

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
Tobias Herold, Stephanie Schneider, Klaus H Metzeler, Martin Neumann, Luise Hartmann, Kathryn G Roberts, Nikola P Konstandin, Philipp A Greif, Kathrin Bräundl, Bianka Ksienzyk,[...]. Haematologica 2017
75
100

Acute lymphoblastic leukaemia.
Hiroto Inaba, Mel Greaves, Charles G Mullighan. Lancet 2013
565
100

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
Akinori Yoda, Yuka Yoda, Sabina Chiaretti, Michal Bar-Natan, Kartik Mani, Scott J Rodig, Nathan West, Yun Xiao, Jennifer R Brown, Constantine Mitsiades,[...]. Proc Natl Acad Sci U S A 2010
217
100

Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.
Adrián Montaño, Jesús Hernández-Sánchez, Maribel Forero-Castro, María Matorra-Miguel, Eva Lumbreras, Cristina Miguel, Sandra Santos, Valentina Ramírez-Maldonado, José Luís Fuster, Natalia de Las Heras,[...]. J Pers Med 2020
1
100

Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Sabina Chiaretti, Monica Messina, Sara Grammatico, Alfonso Piciocchi, Anna L Fedullo, Filomena Di Giacomo, Nadia Peragine, Valentina Gianfelici, Alessia Lauretti, Rohan Bareja,[...]. Br J Haematol 2018
23
100

Targeting mTOR in Acute Lymphoblastic Leukemia.
Carolina Simioni, Alberto M Martelli, Giorgio Zauli, Elisabetta Melloni, Luca M Neri. Cells 2019
22
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.